Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 2 · 66.7%Low 1 · 33.3%Moderate 0 · 0%High 0 · 0%

relapse to heavy drinking ‐ 6 months · alcohol dependent patients

GHB 50mg showed no clear difference in relapse to heavy drinking ‐ 6 months compared with placebo be used (low certainty).

1 finding from 1 review

relapses to heavy drinking ‐ 12 months · alcohol dependent patients

It is very uncertain whether GHB 50mg changes relapses to heavy drinking ‐ 12 months compared with NTX be used (very low certainty).

1 finding from 1 review

Gamma‐hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses 2010 · Cochrane Headline outcomes only
RR 0.55 [0.18, 1.67]
1 study · 55 participants
Very low

relapses to heavy drinking ‐ 12 months · alcohol dependent patients

It is very uncertain whether GHB 50mg changes relapses to heavy drinking ‐ 12 months compared with disulfiram be used (very low certainty).

1 finding from 1 review

Gamma‐hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses 2010 · Cochrane Headline outcomes only
RR 1.48 [0.36, 6.03]
1 study · 59 participants
Very low